Dementia and Hair loss

Summary:

Hair loss is found among people with Dementia, especially for people who are female, 60+ old.

The study analyzes which people have Hair loss with Dementia. It is created by eHealthMe based on reports of 17 people who have Dementia from the Food and Drug Administration (FDA), and is updated regularly. You can use the study as a second opinion to make health care decisions.

With medical big data and AI algorithms, eHealthMe enables everyone to run phase IV clinical trial to detect adverse drug outcomes and monitor effectiveness. Our original studies have been referenced on 600+ peer-reviewed medical publications including The Lancet, Mayo Clinic Proceedings, and Nature. Most recently, phase IV clinial trails for COVID 19 vaccines have been added, check here.



On Jun, 30, 2022

17 people who have Dementia and Hair Loss are studied.


What is Dementia?

Dementia (madness) is found to be associated with 2,194 drugs and 1,611 conditions by eHealthMe.

What is Hair loss?

Hair loss is found to be associated with 3,536 drugs and 3,194 conditions by eHealthMe.

Number of Hair loss in Dementia reports submitted per year:

Would you have Hair loss when you have Dementia?

Gender of people who have Dementia and experienced Hair Loss *:

  • female: 75 %
  • male: 25 %

Age of people who have Dementia and experienced Hair Loss *:

  • 0-1: 0.0 %
  • 2-9: 0.0 %
  • 10-19: 0.0 %
  • 20-29: 0.0 %
  • 30-39: 0.0 %
  • 40-49: 0.0 %
  • 50-59: 0.0 %
  • 60+: 100 %

Common co-existing conditions for these people *:

  1. High Blood Pressure: 3 people, 17.65%
  2. Sleep Disorder: 2 people, 11.76%
  3. Asthma: 2 people, 11.76%
  4. High Blood Cholesterol: 2 people, 11.76%
  5. Type 2 Diabetes: 1 person, 5.88%
  6. Dyskinesia (abnormality or impairment of voluntary movement): 1 person, 5.88%
  7. Acromegaly (body produces too much growth hormone, leading to excess growth of body tissues): 1 person, 5.88%
  8. Affective Disorder (mental disorder): 1 person, 5.88%
  9. Atrial Fibrillation/flutter (atrial fibrillation and flutter are abnormal heart rhythms in which the atria, or upper chambers of the heart, are out of sync with the ventricles): 1 person, 5.88%
  10. Basal Cell Carcinoma (a skin cancer, it rarely metastasizes or kills): 1 person, 5.88%

Common drugs taken by these people *:

  1. Namenda: 4 people, 23.53%
  2. Acidophilus: 2 people, 11.76%
  3. Vitamin D: 2 people, 11.76%
  4. Erivedge: 2 people, 11.76%
  5. Pantoprazole: 2 people, 11.76%
  6. Celexa: 2 people, 11.76%
  7. Xanax: 2 people, 11.76%
  8. Alprazolam: 1 person, 5.88%
  9. Allegra: 1 person, 5.88%
  10. Implanon: 1 person, 5.88%

Common symptoms for these people *:

  1. Appetite - Decreased (decreased appetite occurs when you have a reduced desire to eat): 4 people, 23.53%
  2. Weight Decreased: 3 people, 17.65%
  3. Fatigue (feeling of tiredness): 3 people, 17.65%
  4. Insomnia (sleeplessness): 3 people, 17.65%
  5. Stress And Anxiety: 3 people, 17.65%
  6. Tremor (trembling or shaking movements in one or more parts of your body): 3 people, 17.65%
  7. Dizziness: 3 people, 17.65%
  8. Rashes (redness): 3 people, 17.65%
  9. Hypothyroidism (abnormally low activity of the thyroid gland, resulting in retardation of growth and mental development): 2 people, 11.76%
  10. Weakness: 2 people, 11.76%

* Approximation only. Some reports may have incomplete information.

Do you take medications and have Hair loss?

Check whether Hair loss is associated with a drug or a condition

How to use the study?

You can discuss the study with your doctor, to ensure that all drug risks and benefits are fully discussed and understood.



Related publications that referenced our studies

Related studies

Treatments, associated drugs and conditions:

COVID vaccines that are related to Hair loss:

Common drugs associated with Hair loss:

All the drugs that are associated with Hair loss:

Common conditions associated with Hair loss:

All the conditions that are associated with Hair loss:

How the study uses the data?

The study is based on Hair loss and Dementia, and their synonyms.

Who is eHealthMe?

With medical big data and proven AI algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 600+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.

Recent studies on eHealthMe: